Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Oxford Researchers Aim To Improve Diagnosis of Pneumonia In Children

XTALKS VITALS NEWS

Pediatrics

Specialized equipment like X-ray machines are currently required for doctors to properly diagnose pneumonia and assess how serious it is in a pediatric patient.

Tweetables from this article:

Tweet: 99 percent of all pneumonia-related deaths in children occur in developing nations http://ctt.ec/AXdWd+99 percent of all pneumonia-related deaths in children occur in developing nations.

Tweet: Pediatric death rates can be reduced by 42% if health workers have the tools to accurately diagnose pneumonia http://ctt.ec/b3T35+Pediatric death rates can be reduced by 42 percent if health workers have the tools to accurately diagnose pneumonia.

Share this!

August 4, 2016 | by Sarah Massey, M.Sc.

Pneumonia is the top killer of children under five, worldwide. To improve diagnosis of the potentially life-threatening illness, researchers at Oxford University are developing a less-expensive and easier diagnostic tool for clinicians.

Specialized equipment like X-ray machines are currently required for doctors to properly diagnose pneumonia and assess how serious it is in a pediatric patient. However, 99 percent of all pneumonia-related deaths in children occur in developing nations, and health workers there do not always have access to the proper diagnostic equipment.

“With the nearest hospital hours away, generalist health workers depend on a set of guidelines known as IMCI [Integrated Management of Childhood Illness],” said Elina Naydenova, of Oxford University’s Institute for Biomedical Engineering. “These can sometimes be good at identifying cases of pneumonia but not so good at screening out cases that are not pneumonia.

“There is also huge variability across users. In settings, where there isn’t a clinical expert to set a conclusive diagnosis, the number of unnecessary antibiotic prescriptions has increased as a result – depleting vital drug supplies and adding to the problem of antibiotic-resistant infections,” Naydenova continued. “We wanted to apply smart engineering to develop a robust automated system that was consistently more accurate.”



Pediatric death rates can be reduced by 42 percent if health workers have the tools necessary to accurately diagnose pneumonia and determine the severity of the infection. Based on the diagnosis, decisions must be made on whether the child should be admitted to hospital and whether antibiotics should be given if the infection is bacterial. All of these choices have a major impact on clinical outcomes for the patient, and health workers only have a few basic, portable pieces of equipment with which to make these decisions.

To develop an automated diagnostic tool, the Oxford researchers analyzed data collected from a clinical study conducted in Gambia. Using machine learning techniques, Naydenova and her colleagues worked towards developing an algorithm capable of helping health workers diagnose pneumonia.

“For identifying pneumonia we found four features that can be measured with two pieces of equipment. Heart rate, respiratory rate and oxygen saturation can all be measured using a pulse oximeter,” said Naydenova. “Temperature requires a thermometer. These are things that can be made available to a health worker with basic training.

“Using these four measures, we achieved 98.2% sensitivity and 97.5% specificity, compared to IMCI, where the best performance is 94% sensitivity and 69% specificity,” she continued. These results indicate that the Oxford tool could identify 982 in every 1000 pneumonia cases, and only generate a false-positive result in 2.5 percent of cases.

“We have identified a set of features that could offer an alternative to the combination of X-rays and blood cultures only available in a well-equipped hospital,” said Naydenova. “These will be used in a mobile application linked to a set low-cost diagnostic equipment, which we will be trialing in the next couple of years.”


Keywords: Pneumonia, Pediatrics, Diagnostic Tool


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.